ozanimod 0.23 MG Oral Capsule
- RxCUI
- 2288414
- RxNorm name
- ozanimod 0.23 MG Oral Capsule
- Display name
- ozanimod 0.23 MG Oral Capsule
- Full name
- ozanimod 0.23 MG Oral Capsule
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:09
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZEPOSIA 7-Day Starter Pack | OZANIMOD HYDROCHLORIDE | Celgene Corporation | 93ce2fab-edfb-4804-8074-963071de51e4 | 2026-04-16 | Warnings, Adverse reactions | 2288414 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 93ce2fab-edfb-4804-8074-963071de51e4 | ozanimod 0.23 MG Oral Capsule | PSN | 25 | These highlights do not include all the information needed to use ZEPOSIA safely and effectively. See full prescribing information for ZEPOSIA. ZEPOSIA ® (ozanimod) capsules, for oral use Initial U.S. Approval: 2020 | 20260416 |
| 93ce2fab-edfb-4804-8074-963071de51e4 | ozanimod 0.23 MG (as ozanimod hydrochloride 0.25 MG) Oral Capsule | SY | 25 | These highlights do not include all the information needed to use ZEPOSIA safely and effectively. See full prescribing information for ZEPOSIA. ZEPOSIA ® (ozanimod) capsules, for oral use Initial U.S. Approval: 2020 | 20260416 |
| 93ce2fab-edfb-4804-8074-963071de51e4 | ozanimod 0.23 MG Oral Capsule | SCD | 25 | These highlights do not include all the information needed to use ZEPOSIA safely and effectively. See full prescribing information for ZEPOSIA. ZEPOSIA ® (ozanimod) capsules, for oral use Initial U.S. Approval: 2020 | 20260416 |